Home Relationships among biochemical measures in children with diabetic ketoacidosis
Article
Licensed
Unlicensed Requires Authentication

Relationships among biochemical measures in children with diabetic ketoacidosis

  • Nicole S. Glaser EMAIL logo , Michael J. Stoner , Maria Y. Kwok , Kimberly S. Quayle , Kathleen M. Brown , Jeff E. Schunk , Jennifer L. Trainor , Julie K. McManemy , Leah Tzimenatos , Arleta Rewers , Lise E. Nigrovic , Jonathan E. Bennett , Sage R. Myers , McKenna Smith , T. Charles Casper and Nathan Kuppermann
Published/Copyright: January 16, 2023

Abstract

Objectives

Investigating empirical relationships among laboratory measures in children with diabetic ketoacidosis (DKA) can provide insights into physiological alterations occurring during DKA. We determined whether alterations in laboratory measures during DKA conform to theoretical predictions.

Methods

We used Pearson correlation statistics and linear regression to investigate correlations between blood glucose, electrolytes, pH and PCO2 at emergency department presentation in 1,681 pediatric DKA episodes. Among children with repeat DKA episodes, we also assessed correlations between laboratory measures at the first vs. second episode.

Results

pH and bicarbonate levels were strongly correlated (r=0.64), however, pH and PCO2 were only loosely correlated (r=0.17). Glucose levels were correlated with indicators of dehydration and kidney function (blood urea nitrogen (BUN), r=0.44; creatinine, r=0.42; glucose-corrected sodium, r=0.32). Among children with repeat DKA episodes, PCO2 levels tended to be similar at the first vs. second episode (r=0.34), although pH levels were only loosely correlated (r=0.19).

Conclusions

Elevated glucose levels at DKA presentation largely reflect alterations in glomerular filtration rate. pH and PCO2 are weakly correlated suggesting that respiratory responses to acidosis vary among individuals and may be influenced by pulmonary and central nervous system effects of DKA.


Corresponding author: Nicole Glaser, MD, Department of Pediatrics, University of California Davis, School of Medicine, 2516 Stockton Blvd., Sacramento, CA, 95817, USA, Phone: (916) 734 7098, Fax: (916) 734 7070, E-mail:
A complete list of non-author members of the PECARN DKA FLUID Study Group appears in the Acknowledgments.

Award Identifier / Grant number: U01HD062417

Award Identifier / Grant number: U03MC00008, U03MC00001, U03MC00003, U03MC00006, U0

Acknowledgments

We gratefully acknowledge the participation of our beloved colleague, Aris Garro, MD, MPH (deceased), as co-investigator in this study. Participating co-investigators of the PECARN DKA FLUID Study Group at the time of the design and initiation of the study included the following: UC Davis Medical Center Health, University of California Davis: Simona Ghetti, PhD, Clinton S. Perry III, PhD, James P. Marcin, MD, MPH. Primary Children’s Medical Center, University of Utah: Mary Murray, MD, Jared Henricksen, MD, Brad Poss, MD, J. Michael Dean, MD, MBA. Nationwide Children’s Hospital, Ohio State University: Bema Bonsu, MD, Tensing Maa, MD. Justin Indyk, MD, PhD. Children’s Hospital Colorado, University of Colorado: Marian Rewers, MD, PhD. Peter Mourani, MD. Texas Children’s Hospital, Baylor University. Jake A. Kushner, MD, Laura L. Loftis, MD. Children’s Hospital of Philadelphia, University of Pennsylvania. Monika Goyal, MD, MSCE, Rakesh Mistry, MD, MS, Vijay Srinivasan, MD, Andrew Palladino, MD, Boston Children’s Hospital, Harvard Medical School. Joseph I. Wolfsdorf, MD, Michael S. Agus, MD. Rhode Island Hospital, Brown University, Aris Garro, MD, MPH, Linda Snelling, MD, Charlotte Boney, MD, MS (University of Massachusetts Medical School, Baystate), Children’s National Medical Center, George Washington University, Fran R. Cogen, MD, CDE, Sonali Basu, MD, St. Louis Children’s Hospital, Washington University in St. Louis, Neil H. White, MD, CDE, Nikoleta S. Kolovos, MD, Ann and Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, Donald Zimmerman, MD, Denise Goodman, MD, MS, A.I. DuPont Hospital for Children, Thomas Jefferson University, Andrew D. DePiero, MD, Daniel A. Doyle, MD, Meg A. Frizzola, MD, New York Presbyterian Morgan Stanley Children’s Hospital, Columbia University, David Schnadower, MD, Mary Pat Gallagher, MD, John Scott Baird, MD.

  1. Research funding: Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant U01HD062417) and the Emergency Medical Services for Children Network Development Demonstration Program of the Maternal and Child Health Bureau, Health Resources and Services Administration, under cooperative agreement (awards U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685). The content and conclusions of this article are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by the Health Resources and Services Administration, the Department of Health and Human Services, or the U.S. government. The funding organizations played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: None of the authors have conflicts of interest relevant to the manuscript.

  4. Informed consent: Informed consent was obtained from all individuals included in the PECARN FLUID Trial database. Consent was not required for medical records review for the additional DKA episodes added later to the FLUID Trial database.

  5. Ethical approval: The research related to human use has complied with all of the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration. The Institutional Review Boards at each of the participating institutions approved the study protocol as well as additional medical record review.

References

1. Dhatariya, KKGN, Codner, E, Umpierrez, GE. Diabetic ketoacidosis. Nat Rev Dis Prim 2020;6:40. https://doi.org/10.1038/s41572-020-0165-1.Search in Google Scholar PubMed

2. Halperin, M, Goldstein, M, Richardson, R, Robson, L. Quantitative aspects of hyperglycemia in the diabetic: a theoretical approach. Clin Invest Med 1980;2:127–30.Search in Google Scholar

3. von Oettingen, JWJ, Feldman, HA, Rhodes, ET. Use of serum bicarbonate to substitute for venous pH in new-onset diabetes. Pediatrics 2015;136:e371–7. https://doi.org/10.1542/peds.2015-0156.Search in Google Scholar PubMed PubMed Central

4. Palmer, BFCD. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med 2015;373:548–59. https://doi.org/10.1056/nejmra1503102.Search in Google Scholar PubMed

5. Adrogue, HJLE, Suki, WN, Eknoyan, G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine 1986;65:163–72. https://doi.org/10.1097/00005792-198605000-00004.Search in Google Scholar PubMed

6. Fulop, M. Hyperkalemia in diabetic ketoacidosis. Am J Med Sci 1990;299:164–9. https://doi.org/10.1097/00000441-199003000-00004.Search in Google Scholar PubMed

7. Su, D, Li, J, Guo, M, Li, Y, Ma, S. Clinical analysis of electrolyte disorders in patients with diabetic ketoacidosis. Clin Lab 2021;67:1. https://doi.org/10.7754/clin.lab.2020.200309.Search in Google Scholar

8. Turovsky, ETSM, Kasymov, V, Deitmer, JW, Arroyo, AGD, Ackland, GL, Corneveaux, JJ, et al.. Mechanisms of CO2/H+ sensitivity of astrocytes. J Neurosci 2016;36:10750–8. https://doi.org/10.1523/jneurosci.1281-16.2016.Search in Google Scholar PubMed PubMed Central

9. Lau, EMJ, Carino, G. Inhaled β-agonist therapy and respiratory muscle fatigue as under-recognised causes of lactic acidosis. BMJ Case Rep 2013;2013:bcr2013201015. https://doi.org/10.1136/bcr-2013-201015.Search in Google Scholar PubMed PubMed Central

10. Glaser, N, Wootton-Gorges, S, Kim, I, Tancredi, D, Marcin, J, Muir, A, et al.. Regional brain water content and distribution during diabetic ketoacidosis. J Pediatr 2017;180:170–6. https://doi.org/10.1016/j.jpeds.2016.09.003.Search in Google Scholar PubMed PubMed Central

11. Hoffman, W, Locksmith, J, Burton, E, Hobbs, E, Passmore, G, Pearson-Shaver, A, et al.. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complicat 1998;12:314–20. https://doi.org/10.1016/s1056-8727(98)00012-9.Search in Google Scholar PubMed

12. Fearon, DM, Steele, DW. End-tidal carbon dioxide predicts the presence and severity of acidosis in children with diabetes. Acad Emerg Med 2002;9:1373–8. https://doi.org/10.1197/aemj.9.12.1373.Search in Google Scholar

13. Myers, S, Glaser, N, Trainor, J, Nigrovic, L, Garro, A, Tzimenatos, L, et al.. Frequency and risk factors of acute kidney injury during diabetic ketoacidosis in children and association with neurocognitive outcomes. JAMA Netw Open 2020;3:e2025481. https://doi.org/10.1001/jamanetworkopen.2020.25481.Search in Google Scholar PubMed PubMed Central

14. Feldman-Kiss, D, Li, D, Cleve, R, Sinclair, G, Dubland, J, Wang, L. Interference of ketone bodies on laboratory creatinine measurement in children with DKA: a call for change in testing practices. Pediatr Nephrol 2021;37:1347–53. https://doi.org/10.1007/s00467-021-05324-0.Search in Google Scholar PubMed

Received: 2022-11-08
Accepted: 2022-12-14
Published Online: 2023-01-16
Published in Print: 2023-03-28

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Thyroid – what is a healthy thyroid function test?
  4. Review
  5. Thyroid storm in pediatrics: a systematic review
  6. Opinion Paper
  7. DSD/intersex: historical context and current perspectives
  8. Original Articles
  9. Predictive value of 6 h postoperative parathyroid hormone level on permanent hypoparathyroidism in pediatric total thyroidectomy: a pilot study
  10. Evaluation of a nurse-led counselling intervention on selected outcome variables for parents of children with congenital adrenal hyperplasia
  11. The relationship between estrogen and subsequent growth restriction among adolescents with heavy menstrual bleeding at menarche
  12. An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
  13. Normal bone density but altered geometry in girls with Turner syndrome
  14. Newborn screening for inborn errors of metabolism in a northern Chinese population
  15. Evaluation of serum telomerase activity in normal-weight young girls with polycystic ovary syndrome and its relation to metabolic parameters
  16. Early onset of puberty during COVID-19 pandemic lockdown: experience from two Pediatric Endocrinology Italian Centers
  17. Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty
  18. Short Communications
  19. Long-term experience with the use of a single histrelin implant beyond one year in patients with central precocious puberty
  20. Relationships among biochemical measures in children with diabetic ketoacidosis
  21. Case Reports
  22. Hyperthyroidism in McCune–Albright Syndrome – a case report
  23. Sexual precocity in the setting of parental use of a compounded testosterone cream: case report and review of the literature
  24. Intracardiac thrombosis following intravenous zoledronate treatment in a child with steroid-induced osteoporosis
  25. Identification of a novel mutation in the ALDOB gene in hereditary fructose intolerance
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0570/html
Scroll to top button